• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Antonio di Stasi, Denái R. Milton, +22 authors Stefan O. Ciurea
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2014 (First Publication: 1 December 2014)
  • Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) has been performed primarily with an HLA-matched donor. Outcomes ofContinue Reading
  • Stefan O Ciurea, Victor Eduardo Mulanovich, +24 authors Richard E Champlin
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2012 (First Publication: 1 December 2012)
  • Haploidentical stem cell transplantation (SCT) has been generally performed using a T cell depleted (TCD) graft; however, a high rate of nonrelapse mortality (NRM) has been reported, particularly inContinue Reading
  • Manish Sharma, Farhad Ravandi, +13 authors Marcos de Lima
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2011 (First Publication: 1 December 2011)
  • Patients with acute myeloid leukemia (AML) and internal tandem duplication of FMS-like tyrosine kinase receptor-3 gene (FLT3-ITD) mutation have poor prognoses and are often treated with allogeneicContinue Reading
  • Timothy S. Fenske, Kwang Woo Ahn, +27 authors Mehdi Hamadani
  • Medicine
  • British journal of haematology
  • 2016 (First Publication: 1 July 2016)
  • For diffuse large B-cell lymphoma (DLBCL) patients progressing after autologous haematopoietic cell transplantation (autoHCT), allogeneic HCT (alloHCT) is often considered, although limitedContinue Reading
  • Yago Nieto, Benigno C. Valdez, +19 authors Borje S. Andersson
  • Medicine
  • Cancer
  • 2016 (First Publication: 1 September 2016)
  • BACKGROUND More active high-dose chemotherapy (HDC) regimens are needed for refractory lymphomas. The authors previously combined infusional gemcitabine with busulfan and melphalan (Gem/Bu/Mel)Continue Reading
  • Issa F. Khouri, Rima Saliba, +18 authors Homer A. Macapinlac
  • Medicine
  • Blood
  • 2012 (First Publication: 28 June 2012)
  • In 2008, we reported favorable 5-year outcomes of nonmyeloablative allogeneic stem cell transplantation after fludarabine, cyclophosphamide, rituximab (FCR) conditioning for relapsed andContinue Reading
  • Yago Nieto, Uday R Popat, +15 authors Roy B. Jones
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2013 (First Publication: 1 March 2013)
  • More active high-dose chemotherapy (HDC) regimens are needed for refractory Hodgkin's lymphoma (HL). We report a cohort analysis of 180 consecutive patients with primary refractory or poor-riskContinue Reading
  • Sameh Gaballa, Isabell Ge, +29 authors Stefan O Ciurea
  • Medicine
  • Cancer
  • 2016 (First Publication: 1 November 2016)
  • BACKGROUND High-dose, post-transplantation cyclophosphamide (PTCy) to prevent graft-versus-host disease (GVHD) has improved outcomes in haploidentical (HAPLO) stem cell transplantation (SCT).Continue Reading